rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1994-11-23
|
pubmed:abstractText |
The specificity of tetrafibricin was examined by comparing its activities on GPIIb/IIIa and on the vitronectin receptor (alpha v beta 3) with those of Arg-Gly-Asp-Ser (RGDS) on the same receptors. Tetrafibricin, which inhibited fibrinogen-GPIIb/IIIa binding 10 times more potently than RGDS, was three orders of magnitude less potent compared to RGDS on the inhibition of fibrinogen binding to alpha v beta 3. Furthermore, tetrafibricin potently inhibited platelet adhesion to both fibrinogen and von Willebrand factor. Whereas, there was no significant inhibition observed in the GPIIb/IIIa-independent cellular adhesions. These results suggest that tetrafibricin is highly selective for GPIIb/IIIa.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Bacterial Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen,
http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Integrins,
http://linkedlifedata.com/resource/pubmed/chemical/Macrolides,
http://linkedlifedata.com/resource/pubmed/chemical/Oligopeptides,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Aggregation Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Platelet Membrane Glycoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Cytoadhesin,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Vitronectin,
http://linkedlifedata.com/resource/pubmed/chemical/Vitronectin,
http://linkedlifedata.com/resource/pubmed/chemical/arginyl-glycyl-aspartyl-serine,
http://linkedlifedata.com/resource/pubmed/chemical/tetrafibricin,
http://linkedlifedata.com/resource/pubmed/chemical/von Willebrand Factor
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0006-291X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:day |
14
|
pubmed:volume |
204
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
325-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7524499-Amino Acid Sequence,
pubmed-meshheading:7524499-Animals,
pubmed-meshheading:7524499-Anti-Bacterial Agents,
pubmed-meshheading:7524499-Aorta,
pubmed-meshheading:7524499-Blood Platelets,
pubmed-meshheading:7524499-Cattle,
pubmed-meshheading:7524499-Cells, Cultured,
pubmed-meshheading:7524499-Endothelium, Vascular,
pubmed-meshheading:7524499-Fibrinogen,
pubmed-meshheading:7524499-Glycoproteins,
pubmed-meshheading:7524499-Humans,
pubmed-meshheading:7524499-Integrins,
pubmed-meshheading:7524499-Kinetics,
pubmed-meshheading:7524499-Macrolides,
pubmed-meshheading:7524499-Molecular Sequence Data,
pubmed-meshheading:7524499-Oligopeptides,
pubmed-meshheading:7524499-Platelet Adhesiveness,
pubmed-meshheading:7524499-Platelet Aggregation Inhibitors,
pubmed-meshheading:7524499-Platelet Membrane Glycoproteins,
pubmed-meshheading:7524499-Receptors, Cytoadhesin,
pubmed-meshheading:7524499-Receptors, Vitronectin,
pubmed-meshheading:7524499-Vitronectin,
pubmed-meshheading:7524499-von Willebrand Factor
|
pubmed:year |
1994
|
pubmed:articleTitle |
Tetrafibricin has a high selectivity for GPIIb/IIIa: comparison of the effects of tetrafibricin and RGDS on GPIIb/IIIa and the vitronectin receptor.
|
pubmed:affiliation |
Nippon Roche Research Center, Kanagawa, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|